Search

everythinglearnresearchcommunity

for

Search:↓

COC treatment improves hormone and metabolic levels in PCOS patients.

Choosing the right starting dose of Clomiphene Citrate for ovulation induction in PCOS women is challenging; higher BMI and hormone levels may indicate resistance to the standard dose.

Activating brown fat may help manage PCOS symptoms.

Telogen Effluvium is a condition causing excessive hair loss due to stress, illness, drugs, or hormonal changes, and can be treated with specific products or naturally resolves after 3-4 years.

Brown Adipose Tissue (BAT) could potentially treat Polycystic Ovary Syndrome (PCOS) by controlling energy balance and lipid homeostasis, but more human research is needed.

High Nesfatin-1 and low Vitamin D may increase blood pressure and heart rate in women with PCOS.

Orlistat helped reduce weight and testosterone in obese women with PCOS but did not significantly affect other androgens or cholesterol levels.

A 20-year-old woman with a rare form of Turner syndrome showed improvement with hormonal therapy and needs comprehensive care.

High androgen levels cause skin issues in PCOS, affecting quality of life.

High uric acid levels are more common in PCOS patients, especially those with androgenic PCOS, and are linked with increased cardiovascular risk and other metabolic issues.

Metformin lowers prolactin in women without PCOS but not in those with PCOS, where it reduces other hormones instead.

Lipid Accumulation Product and Free Androgens Index are effective for assessing fatty liver disease risk in women with Polycystic Ovary Syndrome.

Women with Polycystic Ovary Syndrome (PCOS) have lower levels of a substance called DIAPH1 in their blood, which is linked to changes in sugar metabolism and insulin resistance.

Female pattern hair loss is caused by multiple factors and while treatments like topical minoxidil, hormone therapy, and low-level light therapy can help, none can fully cure it.

Abnormal growth factor metabolism may link psoriasis and metabolic syndrome, and obesity can affect psoriasis treatment effectiveness.

Environmental factors and chemicals might affect hormone balance and contribute to common hair loss.

The study concluded that similar pathways regulate hair growth in dogs and mice, and these pathways are disrupted in dogs with Alopecia X, affecting stem cells and hormone metabolism.

New understanding and treatments for hair loss are improving, but more research is needed.

PCOS is common among Indian women, often with metabolic issues, needing better management strategies.

The guideline emphasizes a multidisciplinary approach and informed consent for gender-affirming hormone treatment, with regular follow-ups and individualized care.

PCOS is a common hormonal disorder in women that causes various symptoms and health risks, requiring personalized treatment.

Some common medications may harm male fertility by affecting hormones, sperm production, and sexual function.

Thyroid dysfunction can cause heart issues, and bedside ultrasound helps diagnose cardiac arrest causes.

The guidelines help doctors diagnose and treat hormone-related disorders in women.

Many women with hair loss also have thyroid issues, high blood pressure, and low Vitamin D.

Anabolic androgenic steroids can increase cancer risk and disrupt hormones.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Long-term use of calcineurin inhibitors in transplant patients can cause hormone issues that can be managed with proper care.

Hair graying is caused by damage and cell depletion but might be temporarily reversible with drugs and hormones.

PCOS is a condition causing irregular periods, excess male hormones, and infertility, often managed by targeting insulin resistance and specific symptoms.